Looks like an exciting 2013 from the J.P. Morgan Healthcare Conference

17 of 40

Michael Whitman, President and CEO of Micro Interventional Devices

Michael Whitman, president and CEO of Micro Interventional Devices, came to JPM celebrating major progress for his company, which makes minimally invasive surgical devices designed to help surgeons access the heart's left ventricle during transcatheter aortic valve replacement procedures (TAVR). Toward the end of the conference, the Pennsylvania startup launched in late 2010 announced that it had raised $3.5 million of an expected $5 million Series B round, with the rest expected to close within 90 days. The money will help the company continue a CE mark study, with expectations of a CE mark submission by the 2013 fourth quarter. In the U.S., meanwhile, early discussions are under way with potential CROs to handle domestic research and development work.